2N32

NMR solution structure of the N-terminal domain of NisI, a lipoprotein from Lactococcus lactis which confers immunity against nisin

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
2	2D 1H-13C HSQC aliphatic	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
3	2D 1H-13C HSQC aromatic	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
4	3D CBCA(CO)NH	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
5	3D HNCO	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
6	3D HNCACB	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
7	3D HBHA(CO)NH	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
8	3D H(CCO)NH	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
9	3D C(CO)NH	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
10	3D 1H-15N NOESY	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
11	3D 1H-13C NOESY aliphatic	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
12	3D 1H-13C NOESY aromatic	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298
13	3D HNCACO	50 mM sodium phosphate, 100 mM sodium chloride, 30 uM DSS, 400 uM [U-13C; U-15N] NisI2, 10 % D2O, 90 % H2O	90% H2O/10% D2O	100	6.5	1 atm	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	700
3	Bruker	AVANCE	800
4	Bruker	AVANCE	950
5	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
torsion angle dynamics, water refinement		CCPN_Analysis

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (minimized average structure)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CCPN_Analysis		CCPN
2	data analysis	CCPN_Analysis		CCPN
3	chemical shift assignment	CARA		Keller and Wuthrich
4	data analysis	CARA		Keller and Wuthrich
5	collection	TopSpin		Bruker Biospin
6	data analysis	TopSpin		Bruker Biospin
7	processing	TopSpin		Bruker Biospin
8	refinement	TopSpin		Bruker Biospin
9	collection	OPAL		Luginbuhl, Guntert, Billeter and Wuthrich
10	data analysis	OPAL		Luginbuhl, Guntert, Billeter and Wuthrich
11	processing	OPAL		Luginbuhl, Guntert, Billeter and Wuthrich
12	refinement	OPAL		Luginbuhl, Guntert, Billeter and Wuthrich
13	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
14	refinement	CYANA		Guntert, Mumenthaler and Wuthrich
15	refinement	OPALp		Luginbuhl, Guntert, Billeter and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.